FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410560551> ?p ?o ?g. }

• W2410560551 endingPage "e0155315" @default.
• W2410560551 startingPage "e0155315" @default.
• W2410560551 abstract "Leptomeningeal dissemination of a primary brain tumor is a condition which is challenging to treat, as it often occurs in rather late disease stages in highly pretreated patients. Its prognosis is dismal and there is still no accepted standard of care. We report here a good clinical effect with a partial response in three out of nine patients and a stable disease with improvement on symptoms in two more patients following systemic anti-angiogenic treatment with bevacizumab (BEV) alone or in combination with chemo- and/or radiotherapy in a series of patients with leptomeningeal dissemination from primary brain tumors (diffuse astrocytoma WHO°II, anaplastic astrocytoma WHO°III, anaplastic oligodendroglioma WHO°III, primitive neuroectodermal tumor and glioblastoma, both WHO°IV). This translated into effective symptom control in five out of nine patients, but only moderate progression-free and overall survival times were reached. Partial responses as assessed by RANO criteria were observed in three patients (each one with anaplastic oligodendroglioma, primitive neuroectodermal tumor and glioblastoma). In these patients progression-free survival (PFS) intervals of 17, 10 and 20 weeks were achieved. In three patients (each one with diffuse astrocytoma, anaplastic astrocytoma and primitive neuroectodermal tumor) stable disease was observed with PFS of 13, 30 and 8 weeks. Another three patients (all with glioblastoma) were primary non-responders and deteriorated rapidly with PFS of 3 to 4 weeks. No severe adverse events were seen. These experiences suggest that the combination of BEV with more conventional therapy schemes with chemo- and/or radiotherapy may be a palliative treatment option for patients with leptomeningeal dissemination of brain tumors." @default.
• W2410560551 created "2016-06-24" @default.
• W2410560551 creator A5017640916 @default.
• W2410560551 creator A5019930673 @default.
• W2410560551 creator A5037433157 @default.
• W2410560551 creator A5043063753 @default.
• W2410560551 creator A5049476139 @default.
• W2410560551 creator A5076567865 @default.
• W2410560551 date "2016-06-02" @default.
• W2410560551 modified "2023-10-18" @default.
• W2410560551 title "Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors" @default.
• W2410560551 cites W1206624486 @default.
• W2410560551 cites W129080774 @default.
• W2410560551 cites W190731017 @default.
• W2410560551 cites W1907780553 @default.
• W2410560551 cites W1959628099 @default.
• W2410560551 cites W1964378216 @default.
• W2410560551 cites W1966120507 @default.
• W2410560551 cites W1968588914 @default.
• W2410560551 cites W2001595326 @default.
• W2410560551 cites W2002727873 @default.
• W2410560551 cites W2024611377 @default.
• W2410560551 cites W2033574605 @default.
• W2410560551 cites W2034200080 @default.
• W2410560551 cites W2062171688 @default.
• W2410560551 cites W2063319717 @default.
• W2410560551 cites W2066085965 @default.
• W2410560551 cites W2069510682 @default.
• W2410560551 cites W2072589309 @default.
• W2410560551 cites W2076747699 @default.
• W2410560551 cites W2078248764 @default.
• W2410560551 cites W2078376569 @default.
• W2410560551 cites W2081283472 @default.
• W2410560551 cites W2100693922 @default.
• W2410560551 cites W2101177013 @default.
• W2410560551 cites W2124736921 @default.
• W2410560551 cites W2133616597 @default.
• W2410560551 cites W2140201170 @default.
• W2410560551 cites W2144487043 @default.
• W2410560551 cites W2162643152 @default.
• W2410560551 cites W2163087412 @default.
• W2410560551 cites W2165772224 @default.
• W2410560551 cites W2169063506 @default.
• W2410560551 cites W4247900145 @default.
• W2410560551 cites W2073138096 @default.
• W2410560551 doi "https://doi.org/10.1371/journal.pone.0155315" @default.
• W2410560551 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4890753" @default.
• W2410560551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27253224" @default.
• W2410560551 hasPublicationYear "2016" @default.
• W2410560551 type Work @default.
• W2410560551 sameAs 2410560551 @default.
• W2410560551 citedByCount "15" @default.
• W2410560551 countsByYear W24105605512017 @default.
• W2410560551 countsByYear W24105605512018 @default.
• W2410560551 countsByYear W24105605512019 @default.
• W2410560551 countsByYear W24105605512020 @default.
• W2410560551 countsByYear W24105605512021 @default.
• W2410560551 countsByYear W24105605512022 @default.
• W2410560551 countsByYear W24105605512023 @default.
• W2410560551 crossrefType "journal-article" @default.
• W2410560551 hasAuthorship W2410560551A5017640916 @default.
• W2410560551 hasAuthorship W2410560551A5019930673 @default.
• W2410560551 hasAuthorship W2410560551A5037433157 @default.
• W2410560551 hasAuthorship W2410560551A5043063753 @default.
• W2410560551 hasAuthorship W2410560551A5049476139 @default.
• W2410560551 hasAuthorship W2410560551A5076567865 @default.
• W2410560551 hasBestOaLocation W24105605511 @default.
• W2410560551 hasConcept C126322002 @default.
• W2410560551 hasConcept C142724271 @default.
• W2410560551 hasConcept C143998085 @default.
• W2410560551 hasConcept C2776694085 @default.
• W2410560551 hasConcept C2776755627 @default.
• W2410560551 hasConcept C2776891213 @default.
• W2410560551 hasConcept C2777802072 @default.
• W2410560551 hasConcept C2777931997 @default.
• W2410560551 hasConcept C2778227246 @default.
• W2410560551 hasConcept C2778880634 @default.
• W2410560551 hasConcept C2779083369 @default.
• W2410560551 hasConcept C2779130545 @default.
• W2410560551 hasConcept C2779429289 @default.
• W2410560551 hasConcept C2779434656 @default.
• W2410560551 hasConcept C502942594 @default.
• W2410560551 hasConcept C509974204 @default.
• W2410560551 hasConcept C71924100 @default.
• W2410560551 hasConceptScore W2410560551C126322002 @default.
• W2410560551 hasConceptScore W2410560551C142724271 @default.
• W2410560551 hasConceptScore W2410560551C143998085 @default.
• W2410560551 hasConceptScore W2410560551C2776694085 @default.
• W2410560551 hasConceptScore W2410560551C2776755627 @default.
• W2410560551 hasConceptScore W2410560551C2776891213 @default.
• W2410560551 hasConceptScore W2410560551C2777802072 @default.
• W2410560551 hasConceptScore W2410560551C2777931997 @default.
• W2410560551 hasConceptScore W2410560551C2778227246 @default.
• W2410560551 hasConceptScore W2410560551C2778880634 @default.
• W2410560551 hasConceptScore W2410560551C2779083369 @default.
• W2410560551 hasConceptScore W2410560551C2779130545 @default.
• W2410560551 hasConceptScore W2410560551C2779429289 @default.
• W2410560551 hasConceptScore W2410560551C2779434656 @default.

• next